首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1610884

C臂的全球市場:洞察，競爭情形，市場預測:2030年

C-Arms - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年12月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年C形臂市場規模將達18億美元。預計到 2030 年，該市場將達到 23.4 億美元，2024 年至 2030 年的預測期間複合年增長率為 4.50%。由於癌症、心血管疾病等慢性疾病的增加以及監管審批等產品開發活動的增加，C 型臂市場正在經歷顯著增長。

全球癌症觀察站（2024）估計，到 2030 年，全球新發癌症病例數將達到 2,000 萬至 2,410 萬例。它還指出，亞洲將出現 9,826,539 例癌症病例，歐洲將出現 4,471,422 例癌症病例，拉丁美洲和加勒比地區將出現 1,551,060 例癌症病例，非洲將出現 1,185,216 例癌症病例。 C 型臂對於癌症診斷和治療至關重要，尤其是指導活檢和腫瘤切除等微創手術。這些用於放射治療期間的即時成像，從而能夠精確定位癌組織，同時最大限度地減少對周圍健康組織的損害。

2023 年 10 月，GE HealthCare 宣布 Allia IGS Pulse 獲得美國 FDA 510(k) 批准。 Allia IGS Pulse 採用全新成像鏈，旨在以最佳劑量提供卓越的成像，無論患者體型大小，都能對複雜的心臟病幹預產生巨大影響。

因此，在 2024 年至 2030 年的預測期內，所有上述因素預計將交織在一起推動 C 型臂市場的發展。

本報告提供全球C臂市場相關調查，提供市場概要，以及各類型，不同設備類型，各檢測器類型，各用途，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

Siemens Healthcare GmbH
General Electric Company
Ziehm Imaging GmbH
FUJIFILM Holdings America Corporation
Canon Medical Systems Corporation
Koninklijke Philips N.V.
Shimadzu Corp.
Hologic, Inc.
Eurocolumbus srl
ASSING S.P.A.
DMS Imaging
Trivitron Healthcare
SternMed GmbH
DGT Holdings Corporation
BMI Biomedical International s.r.l.
Idetec Medical Imaging
BPL Medical Technologies
EcoRay Co., Ltd.
ECOTRON
SIMAD s.r.l.

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明和諮詢方式

簡介目錄圖表

Product Code: DIMDCL0330

C-Arms Market by Type (Full-Size C-Arms, Mini C-Arms, and Others), Device Type (Mobile and Fixed), Detector Type (Image Intensifiers and Flat Panel), Application (Orthopedic and Trauma Surgeries, Radiology Surgeries, Neurosurgeries, and Others), End-User (Hospitals, Ambulatory Surgery Centers, Diagnostic Imaging Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the rising instances of chronic disorders and increasing product developmental activities across the globe

The C-arms market was valued at USD 1.80 billion in 2023, growing at a CAGR of 4.50% during the forecast period from 2024 to 2030 to reach USD 2.34 billion by 2030. The C-arms market is experiencing significant growth due to the rising instances of chronic disorders including cancers, cardiovascular diseases, and increasing product developmental activities like regulatory approvals that are acting as major factors contributing to the overall growth of the C-arms market during the forecast period from 2024 to 2030.

C-Arms Market Dynamics:

The Global Cancer Observatory (2024), estimated that the new instances of cancer globally would reach from 20 million to 24.1 million by the year 2030. Moreover, it stated that Asia accounted for 9,826,539 cancer cases, Europe accounted for 4,471,422 cancer cases, LAC accounted for 1,551,060 cancer cases, and Africa accounted for 1,185,216 cancer cases. C-arms are crucial in the diagnosis and treatment of cancer, particularly in guiding minimally invasive procedures like biopsies and tumor resections. These are used in real-time imaging during radiation therapy, allowing precise targeting of cancerous tissues while minimizing damage to surrounding healthy tissue.

As per recent data provided by the World Heart Report (2023), in 2021, it was stated that more than half a billion people were living with cardiovascular diseases globally. According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people were living with CAD around the world. C-arms are vital in diagnosing and treating cardiovascular diseases, especially CAD, by providing real-time imaging during procedures like angioplasty and stent placement, helping guide instruments and improve patient outcomes.

Moreover, in October 2023, GE HealthCare announced that it secured the US FDA 510(k) clearance for the Allia IGS Pulse. The Allia IGS Pulse featured a new imaging chain designed to deliver exceptional imaging at the optimal dose, making a significant impact in complex cardiology interventions, regardless of patient size.

Hence, the interplay of all the above-mentioned factors are expected to drive the market for C-Arms market during the given forecast period from 2024 to 2030.

However, prolonged or repeated exposure to ionizing radiation associated with skin damage, availability of alternative options, and others may restrict the C-Arms market growth.

C-Arms Market Segment Analysis:

In the device type segment of the C-arms market, the mobile C-arms category is expected to have a significant revenue share in the year 2023. This is due to the various key features and application offered by these devices.

Mobile C-arms are advanced imaging devices designed for intraoperative use, offering flexibility and precision in a variety of medical procedures. Key features include real-time fluoroscopy, which provides continuous X-ray imaging, and 3D cone-beam CT capabilities, allowing surgeons to obtain detailed cross-sectional images.

Mobile C-arms are essential in orthopedic surgeries for tasks like fracture fixation and joint replacements, as they provide real-time guidance for placing implants or screws. They are also widely used in cardiovascular procedures, such as pacemaker insertions and endovascular surgeries, where precise navigation through blood vessels is critical. Additionally, mobile C-arms are employed in neuro and spine surgeries for guiding instrumentation placement, in pain management for spinal injections, and in urology for procedures like kidney stone removal.

Rising product developmental activities by regulatory bodies such as clearances in this category are likely to push forward the revenue for same. For example in March 2024, Siemens Healthineers received FDA clearance for the CIARTIC Move, a mobile C-arm equipped with self-driving capabilities.

Therefore, the widespread advantages and uses of mobile C-arms that enhance performance efficiency, solidify the impact on the growth of the overall C-Arms market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall C-arms market:

Among all the regions, North America is estimated to hold a significant revenue share in the C-Arms market. This can be attributed to several factors, including traumatic brain injury, increasing volume of shoulder replacement surgeries, and introduction of new and technologically advanced products by market players that are acting as major factors contributing to the growth of the C-arms market in the North America region during the forecast period from 2024 to 2030.

According to data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US on average. C-arms are used in traumatic brain injury cases for real-time imaging during surgical interventions, such as in the placement of intracranial pressure monitors, external ventricular drains, or during decompressive craniectomies.

According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries were performed annually in the US, encompassing total shoulder replacement, hemi-arthroplasty, and reverse total shoulder replacement. As per the same source, it projects that by 2025, the number of shoulder replacement procedures in the US could range between 174,000 and 350,000.

C-arms are crucial in shoulder replacement surgeries by providing real-time imaging during the procedure, allowing surgeons to visualize joint alignment, implant positioning, and bone structures.

Additionally, in July 2022, FUJIFILM Holdings Corporation announced the US launch of FDR Cross, an innovative hybrid c-arm and portable x-ray solution built for hospitals and ambulatory surgery centers (ASC). The dual-function c-arm was the first of its kind to offer portable fluoroscopic and radiographic imaging on a single platform.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the C-arms market during the forecast period from 2024 to 2030.

C-Arms Market key players:

Some of the key market players operating in the C-arms market include Siemens Healthcare GmbH, General Electric Company, Ziehm Imaging GmbH, FUJIFILM Holdings America Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Shimadzu Corp., Hologic, Inc., Eurocolumbus srl, ASSING S.P.A., DMS Imaging, Trivitron Healthcare, SternMed GmbH, DGT Holdings Corporation, BMI Biomedical International s.r.l., Idetec Medical Imaging, BPL Medical Technologies, EcoRay Co., Ltd., ECOTRON, SIMAD s.r.l., and others.

Recent Developmental Activities in the C-arms Market:

In June 2024, Philips introduced the Zenition 90, a motorized mobile C-arm designed to meet complex vascular requirements and support a wide range of clinical procedures.
In November 2021, FUJIFILM Healthcare Americas announced the launch of the Persona CS mobile fluoroscopy system, a compact mobile C-arm imaging solution designed for rapid and seamless positioning in the operating room (OR) environments.

Key takeaways from the C-Arms Market Report study

Market size analysis for current C-arms market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the C-arms market
Various opportunities available for other competitors in the C-arms market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current C-arms market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for C-arms market growth in the coming future?

Target audience who can be benefited from this C-Arms market report study

C-Arms providers
Research organizations and consulting companies
C-arms related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in C-arms
Various end-users who want to know more about the C-arms market and the latest developments in the C-arms market

Frequently Asked Questions for the C-Arms Market:

1. What are C-Arms?

The C-arm is a versatile medical imaging device that leverages X-ray technology, commonly used in operating rooms for real-time imaging during procedures. It is C-shaped arm holds the X-ray source and detector, allowing for flexible positioning and optimal imaging angles.

2. What is the market for C-Arms?

The C-arms market was valued at USD 1.80 billion in 2023, growing at a CAGR of 4.50% during the forecast period from 2024 to 2030 to reach USD 2.34 billion by 2030.

3. What are the drivers for the C-Arms market?

The C-arms market is experiencing significant growth due to the rising instances of chronic disorders including cancers, cardiovascular diseases, and increasing product developmental activities like regulatory approvals that are acting as major factors contributing to the overall growth of the C-arms market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the C-Arms market?

Some of the major market players operating in the C-arms market include Siemens Healthcare GmbH, General Electric Company, Ziehm Imaging GmbH, FUJIFILM Holdings America Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Shimadzu Corp., Hologic, Inc., Eurocolumbus srl, ASSING S.P.A., DMS Imaging, Trivitron Healthcare, SternMed GmbH, DGT Holdings Corporation, BMI Biomedical International s.r.l., Idetec Medical Imaging, BPL Medical Technologies, EcoRay Co., Ltd., ECOTRON, SIMAD s.r.l., and others.

5. Which region has the highest share in the C-Arms market?

Among all the regions, North America is estimated to hold a significant revenue share in the C-arms market. This can be attributed to several factors, including traumatic brain injury, increasing volume of shoulder replacement surgeries, and introduction of new and technologically advanced products by market players that are acting as major factors contributing to the growth of the C-arms market in the North America region during the forecast period from 2024 to 2030.

1. C-Arms Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. C-Arms Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. C-Arms Market Key Factors Analysis

5.1. C-Arms Market Drivers
- 5.1.1. Rising instances of chronic disorders
- 5.1.2. Increasing product developmental activities
- 5.1.3. Rising number of trauma and accident cases
5.2. C-Arms Market Restraints and Challenges
- 5.2.1. Prolonged or repeated exposure to ionizing radiation associated with skin damage
- 5.2.2. Availability of alternative options
5.3. C-Arms Market Opportunities
- 5.3.1. Adoption of AI technology for accuracy and precision
- 5.3.2. Increasing research and development for the development of surgical-assistance robots

6. C-Arms Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. C-Arms Market Assessment

7.1. By Type
- 7.1.1. Full-Size C-Arms
- 7.1.2. 7.1.2 Mini C-Arms
- 7.1.3. 7.1.3 Others
7.2. By Device Type
- 7.2.1. Mobile
- 7.2.2. Fixed
7.3. By Detector Type
- 7.3.1. Image Intensifiers
- 7.3.2. Flat Panel
7.4. By Application
- 7.4.1. Orthopedic And Trauma Surgeries
- 7.4.2. Radiology Surgeries
- 7.4.3. Neuro Surgeries
- 7.4.4. Others
7.5. By End-User
- 7.5.1. Hospitals
- 7.5.2. Ambulatory Surgical Centres
- 7.5.3. Diagnostic Imaging Centres
- 7.5.4. Others
7.6. By Geography
- 7.6.1. North America
  - 7.6.1.1. United States C-Arms Market Size in USD million (2021-2030)
  - 7.6.1.2. Canada C-Arms Market Size in USD million (2021-2030)
  - 7.6.1.3. Mexico C-Arms Market Size in USD million (2021-2030)
- 7.6.2. Europe
  - 7.6.2.1. France C-Arms Market Size in USD million (2021-2030)
  - 7.6.2.2. Germany C-Arms Market Size in USD million (2021-2030)
  - 7.6.2.3. United Kingdom C-Arms Market Size in USD million (2021-2030)
  - 7.6.2.4. Italy C-Arms market size in USD million (2021-2030)
  - 7.6.2.5. Spain C-Arms Market Size in USD million (2021-2030)
  - 7.6.2.6. Rest of Europe C-Arms Market Size in USD million (2021-2030)
- 7.6.3. Asia-Pacific
  - 7.6.3.1. China C-Arms Market Size in USD million (2021-2030)
  - 7.6.3.2. Japan C-Arms Market Size in USD million (2021-2030)
  - 7.6.3.3. India C-Arms Market Size in USD million (2021-2030)
  - 7.6.3.4. Australia C-Arms Market Size in USD million (2021-2030)
  - 7.6.3.5. South Korea C-Arms Market Size in USD million (2021-2030)
  - 7.6.3.6. Rest of Asia-Pacific C-Arms Market Size in USD million (2021-2030)
- 7.6.4. Rest of the World (RoW)
  - 7.6.4.1. Middle East C-Arms Market Size in USD million (2021-2030)
  - 7.6.4.2. Africa C-Arms Market Size in USD million (2021-2030)
  - 7.6.4.3. South America C-Arms Market Size in USD million (2021-2030)

8. C-Arms Market Company and Product Profiles

8.1. Siemens Healthcare GmbH
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. General Electric Company
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Ziehm Imaging GmbH
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. FUJIFILM Holdings America Corporation
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Canon Medical Systems Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Koninklijke Philips N.V.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Shimadzu Corp.
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Hologic, Inc.
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Eurocolumbus srl
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. ASSING S.P.A.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. DMS Imaging
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Trivitron Healthcare
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. SternMed GmbH
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. DGT Holdings Corporation
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. BMI Biomedical International s.r.l.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Idetec Medical Imaging
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. BPL Medical Technologies
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. EcoRay Co., Ltd.
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. ECOTRON
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. SIMAD s.r.l.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy